Sensor-augmented pump therapy in type 1 diabetes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 15, Issue 2, 2008, Pages 118-122

  Weinzimer, Stuart A ^a,b   Tamborlane, William V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Artificial pancreas; Glucose sensors; Insulin pump; Type 1 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ACCURACY; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; PATIENT SATISFACTION; REVIEW; SELF MONITORING; SENSOR; BLOOD; CLINICAL TRIAL; EQUIPMENT DESIGN; GENETIC PROCEDURES; HUMAN; INSULIN INFUSION; METHODOLOGY; MONITORING;

BIOSENSING TECHNIQUES; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; HUMANS; INSULIN INFUSION SYSTEMS; MONITORING, PHYSIOLOGIC;

EID: 42449145189     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3282f7960b     Document Type: Review

References (30)

1. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002; 324:705-710.
2. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003; 26:1079-1087.
3. Tamborlane WV, Swan KL, Sikes KA, et al. The renaissance of insulin pump therapy in childhood diabetes. Rev Endocr Metab Disord 2006; 7:205-213.
4. Wentholt IME, Hoekstra JBL, DeVries JH. Continuous glucose monitors: the long-awaited watch dogs? Diabetes Technol Ther 2007; 9:399-409.
5. Buckingham B, Caswell K, Wilson DW. Real-time continuous glucose monitoring. Curr Opin Endocrinol Diabetes 2007; 14:288-295. An outstanding review that not only discusses the technology behind glucose sensors and summarizes the clinical studies of CGMs, but also provides some guidelines on 'real-world' use of these devices in clinical practice.
6. Chase HP, Kim LM, Owen SL, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001; 107:222-226.
7. Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001; 24:2030-2034.
8. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003; 111:933-938.
9. Bode B, Gross K, Rikalo N, et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the Guardian Continuous Monitoring System. Diabetes Technol Ther 2004; 6:105-113.
10. Chase HP, Roberts MD, Wightman C, et al. Use of the GlucoWatch Biographer in children with type 1 diabetes. Pediatrics 2003; 111:790-794.
11. Diabetes Research in Children Network Study Group. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005; 28:1101-1106.
12. Diabetes Research in Children Network Study Group. Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005; 28:1929-1935.
13. Garg S, Zisser H, Schwartz S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006; 29:44-50. This study was the first RCT of the DexCom sensor and was one of the first studies to look at reduction of hypoglycemia using sensors.
14. Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006; 29:2644-2649.
15. Diabetes Research in Children, Network. The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1, diabetes. Diabetes Care 2007; 30:59-64.
16. Weinstein RL, Schwartz SL, Brazg RL, et al. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care 2007; 30:1125-1130.
17. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006; 29:2730-2732. This study was one of the first RCTs to show a benefit of real-time sensor-augmented therapy in patients with diabetes.
18. Halvorson M, Carpenter S, Kaiserman K, Kaufman FR. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump. J Pediatr 2007; 150:103-105. This pilot study was the first published trial of real-time sensor-augmented pump therapy in children.
19. Diabetes Research in Children Network Study Group. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007; 151:388-393. This feasibility study, while not a RCT, was important in its focus on practical aspects of device acceptance and satisfaction in the use of real-time devices.
20. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 2007; 9:203-210. This study confirmed the findings of other RCTs that not only did sensor-augmented therapy improve diabetes control, but there seems to be a 'dose-response' effect: more attention to sensor data translates into greater improvements in glycemic control.
21. Raskin P, Bode BW, Marks JB, et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 2003;26:2598-2606.
22. Wainstein J, Metzger M, Boaz M, et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 2005; 22:1037-1046.
23. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28:1568-1573.
24. Simmons D, Thompson CF, Conroy C, Scott DJ. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001; 24:2078-2082.
25. Weber KK, Lohmann T, Busch K, et al. High frequency of unrecognized hypoglycaemias in patients with type 2 diabetes is discovered by continuous glucose monitoring. Exp Clin Endocrinol Diabetes 2007; 115:491-494.
26. Zick R, Petersen B, Richter M, et al. Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with type 2 diabetes on multiple daily insulin injection therapy. Diabetes Technol Ther 2007; 9:483-492.
27. Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract 2007; 77:174-179.
28. McLachlan K, Jenkins A, O'Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol 2007; 47:186-190.
29. Steil GM, Rebrin K, Darwin C, et al. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006; 55:3344-3350. This landmark paper is the first study of a truly closed-loop artificial pancreas in patients with type 1 diabetes. While limited to a brief in-hospital evaluation, the findings from this study provide the rationale for continued development of this technology.
30. Weinzimer SA, Steil GM, Kurtz N, et al. Automated feedback-controlled insulin delivery in children with type 1 diabetes: a preliminary report [abstract]. Diabetes 2006; 55 (Suppl 1):A102.